Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume 21, Issue 3, Pages 347-352Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/0269881107077739
Keywords
NMDA; ketamine; drug abuse; schizophrenia; chronic effects; perceptual organization
Funding
- Economic and Social Research Council [RES-000-23-0945] Funding Source: researchfish
Ask authors/readers for more resources
N-methyl-D-aspartate (NMDA)-receptor antagonists such as ketamine can induce transient schizophrenia-like symptoms and cognitive dysfunctions in healthy volunteers similar to those observed in patients with schizophrenia. Perceptual organization deficits have been documented in schizophrenia and are thought to be related to some symptoms associated with the illness. The current study was designed to determine whether people who repeatedly self-administer ketamine would also show deficits in perceptual organization. Using a psychophysically well-controlled measure of contour integration, we compared a group of recreational users (n = 16) to a group of poty-drug using controls (n = 16). Contour integration performance was measured on the night of drug use and 3 days later when drug free. The results showed that on the night of drug use, ketamine produced a dysfunction in contour integration however, this was not present 3 days later when drug free. Levels of dissociation were also higher in ketamine users only on the night of drug use. These preliminary data provide some support for the role of NMDA-receptor hypofunctioning in dysfunctional coordination of cognitive activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available